{"url_path":"/sec/btai/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1720893/0001104659-26-093710-index.html","accession_number":"0001104659-26-093710","cik":"0001720893","ticker":"BTAI","issuer_name":"BioXcel Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1720893/0001104659-26-093710-index.html","primary_entity_key":"0001720893","primary_entity_name":"BioXcel Therapeutics, Inc."},"word_count":94,"has_tables":true,"body_markdown":"**Item 9.01****Financial Statements and Exhibits.**\n\n \n\n(d)   Exhibits.\n\n \n\n**Ex. No.****Description**\n\n \n\n[10.1](tm2622818d1_ex10-1.htm)[Form of Twelfth Amendment to Credit Agreement and Guaranty and First Amendment to Security Agreement, dated August 10, 2026](tm2622818d1_ex10-1.htm)\n\n \n\n104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\nDate: August 11, 2026\n**BIOXCEL THERAPEUTICS, INC.**\n\n \n \n \n\n \n \n/s/  Richard Steinhart\n\n \nBy:\nRichard Steinhart\n\n \nTitle:\nChief Financial Officer"}